Nimesh KhadkaSenior Product Application SpecialistThermo Fisher Scientific In this interview, Dr. Nimesh Khadka, Senior ...

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...

Researchers have revealed a temporal disruption in the metabolism of obese mice when adapting to starvation despite no significant structural disruptions in the molecular network. This is a ...

Such molecules would be suited to acting as quantum bits, or qubits, the basic unit of information in quantum systems. But ...

For biologists, seeing is believing. But sometimes biologists have a hard time seeing. One particularly vexing challenge is ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

A new method demonstrated by chemists at the University of Chicago shows how to build certain molecules much more efficiently ...

The executive order aims to lower prescription prices, but targets the mechanism for negotiating small molecule drug costs.

A study by researchers at Fred Hutch Cancer Center published in Nature revises the standard story about transcription factors ...